Literature DB >> 16164648

Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.

David Z I Cherney1, Etienne B Sochett, Judith A Miller.   

Abstract

BACKGROUND: Diabetes mellitus reduces female gender-mediated protection against progression of renal disease but the mechanisms responsible for this loss of protection are unknown. The impact of gender on the diabetic hyperfiltration state has not previously been studied. Since hyperfiltration is a factor in the development of diabetic renal disease, and is influenced by hyperglycemia and renin-angiotensin system (RAS) blockade, we examined gender differences in the renal response to hyperglycemia and angiotensin-converting enzyme (ACE) inhibition in young males and females with uncomplicated type 1 diabetes mellitus.
METHODS: Ten male and 12 female normoalbuminuric, normotensive, adolescents with type 1 diabetes mellitus were studied before ACE inhibition during clamped euglycemia and hyperglycemia, and then after 21 days treatment with enalapril (0.1 mg/kg daily x 1 week and then 0.1 mg/kg twice a day x 2 weeks).
RESULTS: During clamped euglycemia, males exhibited significantly higher effective renal plasma flow (ERPF) and renal blood flow (RBF) and a lower renal vascular resistance (RVR). During clamped hyperglycemia, females exhibited reductions in ERPF and RBF, and increased RVR and filtration fraction (FF). Males exhibited no significant renal hemodynamic changes during hyperglycemia. After ACE inhibition treatment, both genders exhibited significant declines in arterial pressure, but only females displayed a reduction in glomerular filtration rate (GFR) and FF.
CONCLUSION: The renal responses to hyperglycemia and ACE inhibition appear to differ between male and female adolescents with uncomplicated type 1 diabetes mellitus. Hyperglycemia-induced changes in RVR and FF in women may account, at least in part, for the loss of gender-based protection in diabetic renal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164648     DOI: 10.1111/j.1523-1755.2005.00588.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  26 in total

1.  Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions.

Authors:  Eline M Rodenburg; Bruno H Stricker; Loes E Visser
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

2.  The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy.

Authors:  J N Harvey
Journal:  Diabetologia       Date:  2011-05-21       Impact factor: 10.122

3.  Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Julie A Lovshin; Sunita K Singh; Genevieve Boulet; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Leif E Lovblom; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Andrew Advani; Etienne Sochett; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Obes Metab       Date:  2019-03-28       Impact factor: 6.577

Review 4.  Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis.

Authors:  Yanjue Shen; Rongrong Cai; Jie Sun; Xue Dong; Rong Huang; Sai Tian; Shaohua Wang
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

5.  Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Authors:  Julie A Lovshin; Geneviève Boulet; Yuliya Lytvyn; Leif E Lovblom; Petter Bjornstad; Mohammed A Farooqi; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Zi Cherney
Journal:  JCI Insight       Date:  2018-01-11

6.  Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Julie A Lovshin; Yuliya Lytvyn; Leif E Lovblom; Alexandra Katz; Geneviève Boulet; Petter Bjornstad; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Hillary A Keenan; Narinder Paul; Vera Bril; David T Wong; Kylen D McReelis; Michael H Brent; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-12-06       Impact factor: 19.112

7.  Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Julie A Lovshin; Genevieve Boulet; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Leif E Lovblom; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Andrew Advani; Etienne Sochett; Bruce A Perkins; David Z I Cherney
Journal:  Am J Kidney Dis       Date:  2019-02-22       Impact factor: 8.860

Review 8.  Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease.

Authors:  Petter Bjornstad; David Z Cherney
Journal:  Curr Diab Rep       Date:  2018-03-19       Impact factor: 4.810

Review 9.  Sex, diabetes and the kidney.

Authors:  Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

10.  Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

Authors:  Kathryn M Thrailkill; Robert C Bunn; Cynthia S Moreau; Gael E Cockrell; Pippa M Simpson; Hannah N Coleman; J Paul Frindik; Stephen F Kemp; John L Fowlkes
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.